JCRRF (JCR Pharmaceuticals Co) Research & Development: $0.0 Mil (TTM As of Dec. 2025)


JCRRF JCR Pharmaceuticals Co Ltd JCRRF
65 GF Score
Price $3.15
GF Value $5.39
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is JCR Pharmaceuticals Co Research & Development?

JCR Pharmaceuticals Co JCRRF 65 Research & Development is $0.0 Mil as of Dec. 2025. GuruFocus rates JCRRF with a GF Score™ of 65/100 and a GF Value™ of $5.39 (Possible Value Trap). The stock has 8 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. JCR Pharmaceuticals Co's Research & Development for the three months ended in Dec. 2025 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $0.0 Mil.

JCR Pharmaceuticals Co  (OTCPK:JCRRF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

JCR Pharmaceuticals Co Research & Development Related Terms

JCR Pharmaceuticals Co Research & Development Historical Data

* Premium members only.

The historical data trend for JCR Pharmaceuticals Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JCR Pharmaceuticals Co Research & Development Chart

JCR Pharmaceuticals Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

JCR Pharmaceuticals Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
JCRRF
65GF Score
JCR Pharmaceuticals Co Ltd JCRRF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JCR Pharmaceuticals Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.0 Mil mean?
JCR Pharmaceuticals Co (JCRRF) has a Research & Development of $0.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on JCR Pharmaceuticals Co and its competitors.
Is JCR Pharmaceuticals Co's Research & Development too high?
JCR Pharmaceuticals Co's current Research & Development is $0.0 Mil. Overall, JCR Pharmaceuticals Co has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does JCR Pharmaceuticals Co's Research & Development compare to LLY and JNJ?
JCR Pharmaceuticals Co's Research & Development of $0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on JCR Pharmaceuticals Co and its competitors. JCR Pharmaceuticals Co's current Research & Development is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JCR Pharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, JCR Pharmaceuticals Co (JCRRF) is currently considered Possible Value Trap. The stock's GF Value™ is $5.39, compared to a current price of $3.15 — trading 41.7% below its estimated fair value. The current Research & Development is $0.0 Mil. JCR Pharmaceuticals Co's overall GF Score™ is 65/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For JCR Pharmaceuticals Co (JCRRF), the current Research & Development is $0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JCR Pharmaceuticals Co (JCRRF) Overvalued in 2026?

Based on GuruFocus' analysis, JCR Pharmaceuticals Co stock appears to be undervalued. The current stock price of $3.15 is trading 41.7% below its estimated GF Value™ of $5.39. GuruFocus considers JCR Pharmaceuticals Co to be Possible Value Trap.

Key valuation signals for JCRRF:

  • Research & Development: $0.0 Mil
  • GF Value™: $5.39 vs. price of $3.15 (41.7% below fair value)
  • GF Score™: 65/100 with 8 warning signs

No single metric tells the full story. See the JCRRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

JCR Pharmaceuticals Co Business Description

Other Exchanges 4552:Japan
Address 3-19 Kasuga-cho, Ashiya, Hyogo, JPN, 659-0021
JCR Pharmaceuticals Co Ltd is a major drug manufacturing company proactively engaged in the research of enzymes and proteins. The company maintains a focus toward developing value-added treatment options to address unmet medical needs. JCR utilizes international partnerships as a component of its growth strategy. The vast majority of JCR's revenue is generated from its pharmaceutical operations, followed by medical devices and laboratory equipment. A portion of the company's sales are derived from licensing agreements.
65GF Score

Get the complete analysis for JCRRF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.15
Price
$5.39
GF Value